| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
16,290 |
15,234 |
$1.06M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,269 |
10,050 |
$973K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,814 |
2,806 |
$265K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,883 |
4,871 |
$213K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,139 |
2,000 |
$176K |
| 99205 |
Prolong outpt/office vis |
926 |
926 |
$164K |
| 90461 |
|
2,750 |
2,745 |
$102K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
779 |
777 |
$72K |
| 99215 |
Prolong outpt/office vis |
422 |
408 |
$50K |
| 96127 |
|
10,624 |
10,223 |
$46K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,904 |
1,891 |
$32K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
902 |
878 |
$28K |
| 92552 |
|
762 |
761 |
$18K |
| 87428 |
|
288 |
282 |
$15K |
| 99173 |
|
416 |
414 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
209 |
204 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
453 |
446 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
868 |
865 |
$7K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
485 |
437 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
40 |
40 |
$4K |
| 87634 |
|
57 |
56 |
$3K |
| 0071A |
|
88 |
84 |
$3K |
| 0072A |
|
85 |
78 |
$3K |
| 99460 |
|
39 |
39 |
$3K |
| 99201 |
|
56 |
56 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
138 |
134 |
$2K |
| 87807 |
|
146 |
143 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
122 |
58 |
$1K |
| 36416 |
|
530 |
487 |
$1K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
32 |
32 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
79 |
78 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
12 |
12 |
$1K |
| 0002A |
|
15 |
15 |
$600.00 |
| 0001A |
|
13 |
13 |
$520.00 |
| 99177 |
|
84 |
84 |
$387.38 |
| 90686 |
|
883 |
878 |
$376.87 |
| 36415 |
Collection of venous blood by venipuncture |
139 |
128 |
$307.77 |
| 90473 |
|
14 |
14 |
$194.60 |
| 92551 |
|
15 |
15 |
$173.60 |
| 80061 |
Lipid panel |
13 |
13 |
$156.65 |
| 83655 |
|
12 |
12 |
$130.80 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
24 |
24 |
$97.28 |
| 90697 |
|
126 |
126 |
$0.00 |
| 90723 |
|
114 |
114 |
$0.00 |
| 90647 |
|
91 |
90 |
$0.00 |
| 90680 |
|
94 |
94 |
$0.00 |
| 91307 |
|
183 |
164 |
$0.00 |
| 90716 |
|
24 |
24 |
$0.00 |
| 90670 |
|
613 |
613 |
$0.00 |
| 90671 |
|
118 |
118 |
$0.00 |
| 90707 |
|
24 |
24 |
$0.00 |
| 91300 |
|
52 |
49 |
$0.00 |
| 90672 |
|
63 |
63 |
$0.00 |
| 90633 |
|
37 |
37 |
$0.00 |
| 90756 |
|
29 |
29 |
$0.00 |